Palisade Bio (PALI) Interest Expenses (2010 - 2026)
Palisade Bio (PALI) posted quarterly Interest Expenses of $1000.0 for Q1 2026, little changed year-over-year from $1000.0 in Q1 2025, and down 80.0% quarter-over-quarter from $5000.0 in Q4 2025.
Powered by 
Analysis
Palisade Bio (PALI) Interest Expenses (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has reported Interest Expenses for 17 consecutive years, with $1000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses changed 0.0% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $13000.0 (down 7.14% YoY), while the FY2025 annual figure was $27.3 million, down 15.96% from the prior year.
- Interest Expenses slipped to $1000.0 in Q1 2026 per PALI's latest filing, from $5000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $35.6 million in Q1 2023 and bottomed at $1000.0 in Q1 2025.
- Historically, Interest Expenses has averaged $2.1 million across 5 years, with a median of $6000.0 in 2024.
- Annual changes were most pronounced in 2023 — Interest Expenses soared 82793.02% — and 2024, when it sank 99.96%.
- Palisade Bio's Interest Expenses stood at $2000.0 in 2022, then surged by 100.0% to $4000.0 in 2023, then jumped by 50.0% to $6000.0 in 2024, then fell by 16.67% to $5000.0 in 2025, then tumbled by 80.0% to $1000.0 in 2026.
- Business Quant data shows PALI's Interest Expenses at $1000.0 in Q1 2026, $5000.0 in Q4 2025, and $5000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Palisade Bio | 441.79 Mn | 316.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 655,000.00 |
| Mar 31, 2021 | 1.71 Mn |